Results for tag: "Asciminib"

Asciminib is a type of leukemia drug used to treat chronic myeloid leukemia (CML). It is a tyrosine kinase inhibitor (TKI) that works by blocking the activity of the BCR-ABL protein, which is responsible for the uncontrolled growth of cancer cells in CML. It is used in combination with other drugs to treat CML, and is also used to treat other types of leukemia, such as acute lymphoblastic leukemia (ALL). Asciminib is a relatively new drug, and is still in the early stages of development. It has been approved by the US Food and Drug Administration (FDA) for the treatment of CML, and is currently being studied for its potential use in other types of leukemia. Asciminib is marketed by several companies, including Novartis, Bristol-Myers Squibb, and Pfizer. It is also available in generic form from several generic drug manufacturers. Show Less Read more